Riskpilot← Back to searchSign inGet full accessTermino C 13235 AB
ABDissolvedOrg 5567776843General medical practice activities · NACE 8621Est. 20090 employees
Revenue 2024
SEK 0
EBITDA margin
—
+5% vs 2023
Equity ratio
81.3%
Financial strength
Net profit 2024
SEK 6,5M
+2422% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | +5% |
| Net profit | SEK 6,5M | +2422% |
| Total assets | SEK 8,2M | -2% |
| Equity | SEK 6,6M | -20% |
| Employees | 0 | — |
Legal name
Termino C 13235 AB
Org number
5567776843
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 februari 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −21 | −32 | −20 | −21 | −20 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −21 | −32 | −20 | −21 | −20 |
| Net financials | 153 | 532 | 962 | 346 | 8 246 |
| Profit before tax | 132 | 500 | 942 | 325 | 8 226 |
| Tax | −28 | −86 | −194 | −66 | −1 693 |
| Net profit | 104 | 414 | 748 | 259 | 6 533 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 827 | 8 976 | 9 592 | 8 286 | 8 160 |
| Equity | 8 603 | 8 833 | 9 394 | 8 257 | 6 633 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 224 | 143 | 199 | 29 | 1 526 |
| Total debt | 224 | 143 | 199 | 29 | 1 526 |
EBITDA margin
-1967500.0%
This company
15.8%
Market median
-12452632% vs market
20202024
Equity ratio
81.3%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
98.5%
This company
18.4%
Market median
+435% vs market
20202024
Net profit margin
653288600.0%
This company
8.1%
Market median
+8065291258% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AL Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
EC Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 13235 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Louise Andrén | Chief Executive Officer | 0 companies |
| Eva Camilla Beijron | Audit | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Göran Eric Hammarberg | Deputy Board Member | 0 companies |